Tahnee Saunders

Dr. Tahnee Saunders

Ubiqutin Signalling Division, WEHI, Parkville 3052, Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2022 in Science Immunology
Verified
Journal Article
Closed access
FAFatemeh Adiliaghdam
Fatemeh Adiliaghdam
HAHajera Amatullah
Hajera Amatullah
SDSreehaas Digumarthi
Sreehaas Digumarthi
Tahnee SaundersTahnee Saunders
Tahnee Saunders
RRRaza-Ur Rahman
Raza-Ur Rahman
KJKate L. Jeffrey
Kate L. Jeffrey
Altered enteric microorganisms in concert with host genetics shape inflammatory bowel disease (IBD) phenotypes. However, insight is limited to bacteria and fungi. We found that eukaryotic viruses and bacteriophages (collectively, the virome), enriched from non-IBD, noninflamed human colon resections, actively elicited atypical anti-inflammatory innate immune programs. Conversely, ulcerative colitis or Crohn’s disease colon resection viromes provoked inflammation, which was successfully dampened by non-IBD viromes. The IBD colon tissue virome was perturbed, including an increase in the enterovirus B species of eukaryotic picornaviruses, not previously detected in fecal virome studies. Mice humanized with non-IBD colon tissue viromes were protected from intestinal inflammation, whereas IBD virome mice exhibited exacerbated inflammation in a nucleic acid sensing–dependent fashion. Furthermore, there were detrimental consequences for IBD patient–derived intestinal epithelial cells bearing loss-of-function mutations within virus sensor MDA5 when exposed to viromes. Our results demonstrate that innate recognition of IBD or non-IBD human viromes autonomously influences intestinal homeostasis and disease phenotypes. Thus, perturbations in the intestinal virome, or an altered ability to sense the virome due to genetic variation, contribute to the induction of IBD. Harnessing the virome may offer therapeutic and biomarker potential.

4 May 2023 in The EMBO Journal
Verified
Journal Article
Open access
KBKatherine R Balka
Katherine R Balka
RVRajan Venkatraman
Rajan Venkatraman
Tahnee SaundersTahnee Saunders
Tahnee Saunders
ASAngus Shoppee
Angus Shoppee
EPEe Shan Pang
Ee Shan Pang
Dominic De NardoDominic De Nardo
Dominic De Nardo
CGAS‐STING signalling is induced by detection of foreign or mislocalised host double‐stranded (ds)DNA within the cytosol. STING acts as the major signalling hub, where it controls production of type I interferons and inflammatory cytokines. Basally, STING resides on the ER membrane. Following activation STING traffics to the Golgi to initiate downstream signalling and subsequently to endolysosomal compartments for degradation and termination of signalling. While STING is known to be degraded within lysosomes, the mechanisms controlling its delivery remain poorly defined. Here we utilised a proteomics‐based approach to assess phosphorylation changes in primary murine macrophages following STING activation. This identified numerous phosphorylation events in proteins involved in intracellular and vesicular transport. We utilised high‐temporal microscopy to track STING vesicular transport in live macrophages. We subsequently identified that the endosomal complexes required for transport (ESCRT) pathway detects ubiquitinated STING on vesicles, which facilitates the degradation of STING in murine macrophages. Disruption of ESCRT functionality greatly enhanced STING signalling and cytokine production, thus characterising a mechanism controlling effective termination of STING signalling.

31 March 2017 in Science Immunology
Verified
Journal Article
Closed access
PDF file
SMStuti Mehta
Stuti Mehta
DCD. Alexander Cronkite
D. Alexander Cronkite
MBMegha Basavappa
Megha Basavappa
Tahnee SaundersTahnee Saunders
Tahnee Saunders
FAFatemeh Adiliaghdam
Fatemeh Adiliaghdam
KJKate L. Jeffrey
Kate L. Jeffrey
Epigenetic “readers” that recognize defined posttranslational modifications on histones have become desirable therapeutic targets for cancer and inflammation. SP140 is one such bromodomain- and plant homeodomain (PHD)–containing reader with immune-restricted expression, and single-nucleotide polymorphisms (SNPs) within SP140 associate with Crohn’s disease (CD). However, the function of SP140 and the consequences of disease-associated SP140 SNPs have remained unclear. We show that SP140 is critical for transcriptional programs that uphold the macrophage state. SP140 preferentially occupies promoters of silenced, lineage-inappropriate genes bearing the histone modification H3K27me3, such as the HOXA cluster in human macrophages, and ensures their repression. Depletion of SP140 in mouse or human macrophages resulted in severely compromised microbe-induced activation. We reveal that peripheral blood mononuclear cells (PBMCs) or B cells from individuals carrying CD-associated SNPs within SP140 have defective SP140 messenger RNA splicing and diminished SP140 protein levels. Moreover, CD patients carrying SP140 SNPs displayed suppressed innate immune gene signatures in a mixed population of PBMCs that stratified them from other CD patients. Hematopoietic-specific knockdown of Sp140 in mice resulted in exacerbated dextran sulfate sodium (DSS)–induced colitis, and low SP140 levels in human CD intestinal biopsies correlated with relatively lower intestinal innate cytokine levels and improved response to anti–tumor necrosis factor (TNF) therapy. Thus, the epigenetic reader SP140 is a key regulator of macrophage transcriptional programs for cellular state, and a loss of SP140 due to genetic variation contributes to a molecularly defined subset of CD characterized by ineffective innate immunity, normally critical for intestinal homeostasis.

23 February 2024 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
Tahnee SaundersTahnee Saunders
Tahnee Saunders
SWSimon P. Windley
Simon P. Windley
GGGediminas Gervinskas
Gediminas Gervinskas
KBKatherine R. Balka
Katherine R. Balka
CRCaitlin Rowe
Caitlin Rowe
KMKate McArthur
Kate McArthur
During apoptosis mediated by the intrinsic pathway, BAX/BAK triggers mitochondrial permeabilization and the release of cytochrome-c, followed by a dramatic remodelling of the mitochondrial network that results in mitochondrial herniation and the subsequent release of pro-inflammatory mitochondrial components. Here, we show that mitochondrial herniation and subsequent exposure of the inner mitochondrial membrane (IMM) to the cytoplasm, initiates a unique form of mitophagy to deliver these damaged organelles to lysosomes. IMM-induced mitophagy occurs independently of canonical PINK1/Parkin signalling and is driven by ubiquitination of the IMM. Our data suggest IMM-induced mitophagy is an additional safety mechanism that cells can deploy to contain damaged mitochondria. It may have particular relevance in situations where caspase activation is incomplete or inhibited, and in contexts where PINK1/Parkin-mitophagy is impaired or overwhelmed.

9 September 2024 in bioRxiv
Verified
Preprint
Open access
WLWai Kit Lam
Wai Kit Lam
RLRuna Lindblom
Runa Lindblom
BMBridget Milky
Bridget Milky
PMParis Mazzachi
Paris Mazzachi
MHMarjan Hadian-Jazi
Marjan Hadian-Jazi
MLMichael Lazarou
Michael Lazarou
Defects in neuronal mitophagy have been linked to neurodegenerative diseases including Parkinson’s disease. However, despite the importance of mitophagy in neuronal homeostasis, the mechanistic basis for neurodegeneration when mitophagy is defective is unclear. Here, using human neurons, we discover that presynapses are mitophagy pit stops for damaged axonal mitochondria. We show that while mitochondrial damage and PINK1/Parkin activation events are distributed throughout axons, mitophagy initiation and autophagosome formation are restricted to presynapses, which we show contain the machineries required for mitophagy. Being the primary sites of axonal mitophagy, presynapses were vulnerable when PINK1/Parkin mitophagy was defective. We observed local cytochrome c release within presynapses from an accumulation of damaged mitochondria. This resulted in downstream degradative caspase activation, defining a mechanism for neurodegeneration. Pharmacological rescue of axon degeneration was achieved through synthetic upregulation of receptor mediated mitophagy with the clinically approved compound Roxadustat, revealing a potential therapeutic avenue for disease.

11 November 2021 in Immunology & Cell Biology
Verified
Journal Article
Open access
PDF file
MSMary Speir
Mary Speir
ACAmy H Chan
Amy H Chan
DSDaniel S Simpson
Daniel S Simpson
TKTashbib Khan
Tashbib Khan
Tahnee SaundersTahnee Saunders
Tahnee Saunders
Georgia Atkin-SmithGeorgia Atkin-Smith
Georgia Atkin-Smith
Click on the article title to read more.